Citation: Zhang Weina, Huang Zhongbing, Pu Ximing, Chen Xianchun, Yin Guangfu, Wang Lei, Zhang Fei, Gao Fabao. Fabrication of doxorubicin and chlorotoxin-linked Eu-Gd₂O₃ nanorods with dual-model imaging and targeted therapy of brain tumor[J]. Chinese Chemical Letters, ;2020, 31(1): 285-291. doi: 10.1016/j.cclet.2019.04.018 shu

Fabrication of doxorubicin and chlorotoxin-linked Eu-Gd₂O₃ nanorods with dual-model imaging and targeted therapy of brain tumor

Zhang Weina ^a ,
Huang Zhongbing ^a,*, ,
Pu Ximing ^a ,
Chen Xianchun ^a ,
Yin Guangfu ^a ,
Wang Lei ^b ,
Zhang Fei ^a ,
Gao Fabao ^b,*,

a.
College of Materials Science and Engineering, Sichuan University, Chengdu 610065, China
b.
Molecular Imaging Center, Department of Radiology, West China Hospital of Sichuan University, Chengdu 610093, China

zbhuang@scu.edu.cn

gaofabao@yahoo.com

Received Date: 2 February 2019
Revised Date: 4 April 2019
Accepted Date: 9 April 2019
Available Online: 10 January 2019

Figures(4)

It is urgent to find a technology accurately to better diagnose and treat to brain tumor. Eu-doped Gd₂O₃ nanorods (Eu-Gd₂O₃ NRs) with paramagnetic and fluorescent properties were conjugated with doxorubicin (Dox) and chlorotoxin (CTX) via PEGylation, hydrazone bond and sulfur bond (named as CTXNRs-Dox), and these NRs could release more Dox in lower pH environment. The results of cell experiments indicated that CTX-NRs-Dox had obvious targeting and toxic effects on U251 cells, as well as good fluorescence imaging behavior. The orthotopic glioma-transplanted mice models were constructed via the intracranial injection of glioma cells (U87MG). The result of experiments after the tail-vein injection of the prepared NRs suggested that CTX-NRs-Dox could target to brain tumors via the long-time blood circulation, leading to their obvious contrast enhancement of MR imaging of the intracranial tumor and their significant inhibitory effect on the growth and metastasis of brain tumors. A mechanism of synergistic effect of CTX-NRs-Dox on targeting and inhabiting the brain tumor was proposed. Our research suggested that CTX-NRs-Dox had potential application prospect in the detection and treatment of glioma.
- Brain tumor,
- Dual-model imaging,
- Doxorubicin,
- Chlorotoxin,
- Eu-Gd₂O₃ nanorods,
- Targeted therapy
1. [1]
  N.A.O. Bush, S.M. Chang, M.S. Berger, Neurosurg. Rev. 40(2017) 1-14. doi: 10.1007/s10143-016-0709-8
2. [2]
  A. Omuro, L.M. DeAngelis, JAMA 310(2013) 1842-1850. doi: 10.1001/jama.2013.280319
3. [3]
  Z. Wu, Z. Huang, G. Yin, et al., J. Meter. Chem. B 5(2017) 4863-4875. doi: 10.1039/C7TB00833C
4. [4]
  H. Noushmehr, D.J. Weisenberger, K. Diefes, et al., Cancer Cell 17(2010) 510-522. doi: 10.1016/j.ccr.2010.03.017
5. [5]
  Z. Dai, S. Li, P. Zhu, et al., Bioorg. Med. Chem. Lett. 27(2017) 2863-2867. doi: 10.1016/j.bmcl.2017.04.075
6. [6]
  R. Huang, W. Ke, L. Han, et al., Biomaterials 32(2011) 2399-2406. doi: 10.1016/j.biomaterials.2010.11.079
7. [7]
  H. Kao, S. Chiang, H. Chung, F.Y. Tsai, C. Chen, Biomed. Res. Int. 2013(2013) 1-14.
8. [8]
  M. Ideguchi, K. Kajiwara, H. Goto, et al., J. Neuro-Oncol. 123(2015) 289-297. doi: 10.1007/s11060-015-1797-y
9. [9]
  C. Wu, G. Lin, Z. Lin, et al., World J. Surg. Oncol. 13(2015) 97. doi: 10.1186/s12957-015-0496-7
10. [10]
  N.R. Datta, R. David, R.K. Gupta, J. Cancer Res. Ther. 67(2018) 9-13.
11. [11]
  M. Milosevic, S. Voruganti, R. Blend, et al., Radiother. Oncol. 47(1998) 277-284. doi: 10.1016/S0167-8140(97)00232-6
12. [12]
  K.I. Ly, E.R. Gerstner, Curr. Treat Option Oncol. 19(2018) 40. doi: 10.1007/s11864-018-0558-5
13. [13]
  M. Toussaint, S. Pinel, F. Auger, et al., Theranostics 7(2017) 436-451. doi: 10.7150/thno.17218
14. [14]
  J. Hempel, C. Brendle, B. Bender, et al., J. Neuro-Oncol. 139(2018) 373-381. doi: 10.1007/s11060-018-2872-y
15. [15]
  T. Xie, X. Chen, J. Fang, et al., J. Magn. Reson. Imaging 47(2018) 1099-1111. doi: 10.1002/jmri.25835
16. [16]
  C.I. Olariu, H.H.P. Yiu, L. Bouffier, et al., J. Mater. Chem. 21(2011) 12650. doi: 10.1039/c1jm11370d
17. [17]
  P. Lebdusková, A. Sour, L. Helm, et al., Dalton Trans. 28(2006) 3399-3406.
18. [18]
  J. Li, S. Wang, C. Wu, Y. Dai, et al., Biosens. Bioelectron. 86(2016) 1047-1053. doi: 10.1016/j.bios.2016.07.044
19. [19]
  L. Wang, H. Lin, L. Ma, J. Jin, et al., Nanoscale 13(2017) 4516-4523.
20. [20]
  W. Fang, Y. Wei, J. Innov. Opt. Health Sci. 9(2016) 1630006. doi: 10.1142/S1793545816300068
21. [21]
  B. Cai, Z. Huang, Z. Wu, et al., Dalton Trans. 45(2016) 14063-14070. doi: 10.1039/C6DT02304E
22. [22]
  S.L. Mekuria, T.A. Debele, H. Tsai, ACS Appl. Mater. Interfaces 9(2017) 6782-6795. doi: 10.1021/acsami.6b14075
23. [23]
  J. Liu, X. Tian, N. Luo, et al., Langmuir 30(2014) 13005-13013. doi: 10.1021/la503228v
24. [24]
  A. Saha, S.C. Mohanta, K. Deka, P. Deb, P.S. Devi, ACS Appl. Mater. Interfaces 9(2017) 4126-4141. doi: 10.1021/acsami.6b12804
25. [25]
  A. Rammohan, G. Mishra, B. Mahaling, et al., ACS Appl. Mater. Interfaces 8(2016) 350-362. doi: 10.1021/acsami.5b08885
26. [26]
  C. Zhou, H. Wu, C. Huang, M. Wang, N. Jia, Part. Part. Syst. Charact. 31(2014) 675-684. doi: 10.1002/ppsc.201300342
27. [27]
  M. Ahre'n, L. Selegård, A. Klasson, et al., Langmuir 26(2010) 5753-5762. doi: 10.1021/la903566y
28. [28]
  C. Sun, O. Veiseh, J. Gunn, et al., Small 4(2008) 372-379. doi: 10.1002/smll.200700784
29. [29]
  P. Caravan, J.J. Ellison, Chem. Rev. 99(1999) 2293-2352. doi: 10.1021/cr980440x
30. [30]
  Y. Deng, H. Wang, W. Gu, et al., J. Mater. Chem. B 2(2014) 1521-1529. doi: 10.1039/C3TB21613F
31. [31]
  R. Huang, L. Han, J. Li, et al., Biomaterials 32(2011) 5177-5186. doi: 10.1016/j.biomaterials.2011.03.075
32. [32]
  O. Cohen-Inbar, M. Zaaroor, J. Clin. Neurosci. 33(2016) 52-58. doi: 10.1016/j.jocn.2016.04.012
33. [33]
  F.M. Kievit, O. Veiseh, C. Fang, et al., ACS Nano 4(2010) 4587-4594. doi: 10.1021/nn1008512
34. [34]
  W. Qiao, L. Zhao, S. Wu, et al., J. Neuro-Oncol. 133(2017) 287-295. doi: 10.1007/s11060-017-2456-2
35. [35]
  Y. Yang, Z. Huang, X. Pu, et al., Cell Proliferat. (2018) e12486.
36. [36]
  L. Zhao, J. Zhu, ACS Appl. Mater. Interfaces 7(2015) 19798-19808. doi: 10.1021/acsami.5b05836
37. [37]
  X.S. Wu, X.C. Jian, B. Yin, Z.J. He, Chin. J. Cancer 29(2010) 626-630. doi: 10.5732/cjc.009.10359
38. [38]
  Y. Cheng, J. Zhao, W. Qiao, K. Chen, Am. J. Nucl. Med. Mol. Imaging 4(2014) 385-405.
39. [39]
  M. Li, M. Gao, Y. Fu, et al., Colloid Surf. B 140(2016) 11-18. doi: 10.1016/j.colsurfb.2015.12.025
40. [40]
  Q. Mu, M. Jeon, M. Hsiao, et al., Adv. Healthc. Mater. 4(2015) 1236-1245.
41. [41]
  G. NH, J. Li, Nanomed-Nanotechnol. 7(2016) 1000393.
42. [42]
  Y. Cui, M. Zhang, F. Zeng, et al., ACS Appl. Mater. Interfaces 8(2016) 32159-32169. doi: 10.1021/acsami.6b10175
43. [43]
  R. Mustafa, Y. Luo, Y. Wu, R. Guo, X. Shi, Nanomater.-Basel 5(2015) 1716-1731. doi: 10.3390/nano5041716
44. [44]
  J. Sui, Y. Cui, H. Cai, et al., Nanoscale 9(2017) 2755-2767. doi: 10.1039/C6NR09639E
45. [45]
  C. Carvalho, Curr. Med. Chem. 16(2009) 3267-3285. doi: 10.2174/092986709788803312
46. [46]
  D. Coman, Y. Huang, J.U. Nmr, Biomedicine 29(2016) 309-319.
47. [47]
  A. Ponta, Y. Bae, Pharm. Res-Dordr. 27(2010) 2330-2342. doi: 10.1007/s11095-010-0120-z
48. [48]
  Z. Wu, Z. Huang, G. Yin, L. Wang, F. Gao, J. Colloid Interface Sci. 466(2016) 1-11. doi: 10.1016/j.jcis.2015.10.048
49. [49]
  G. Gu, Q. Hu, X. Feng, et al., Biomaterials 35(2014) 8215-8226. doi: 10.1016/j.biomaterials.2014.06.022
50. [50]
  D. Lu, X. Wen, J. Liang, X. Zhang, et al., Chin. J. Polym. Sci. 26(2008) 369-374. doi: 10.1142/S0256767908003023
51. [51]
  S. Yu, Z. Wang, G. Wu, Y. Wang, et al., Acta Polym. Sin. 12(2012) 427-432. doi: 10.3724/SP.J.1105.2012.11222
52. [52]
  H. Li, S. Bian, Y. Huang, et al., J. Biomed. Mater. Res. A 102(2014) 150-159. doi: 10.1002/jbm.a.34680
53. [53]
  F. Meng, Y. Zhong, R. Cheng, C. Deng, Z. Zhong, Nanomed.-UK 9(2014) 487-499. doi: 10.2217/nnm.13.212
54. [54]
  D. Bi, L. Zhao, R. Yu, et al., Drug Deliv. 25(2018) 564-575. doi: 10.1080/10717544.2018.1440447
55. [55]
  W. Cheng, C. Liang, L. Xu, et al., Small 13(2017) 1700623. doi: 10.1002/smll.201700623
56. [56]
  Y. Lin, W. Yao, Y. Cheng, et al., J. Mater. Chem. 22(2012) 5684. doi: 10.1039/c2jm15133b
1. [1]
  Shuheng Zhang , Yuanyuan Zhang , Wanyu Wang , Yuzhu Hu , Xinchuan Chen , Bilan Wang , Xiang Gao . A combination strategy of DOX and VEGFR-2 targeted inhibitor based on nanomicelle for enhancing lymphoma therapy. Chinese Chemical Letters, 2024, 35(12): 109658-. doi: 10.1016/j.cclet.2024.109658
2. [2]
  Jiangshan Xu , Weifei Zhang , Zhengwen Cai , Yong Li , Long Bai , Shaojingya Gao , Qiang Sun , Yunfeng Lin . Tetrahedron DNA nanostructure/iron-based nanomaterials for combined tumor therapy. Chinese Chemical Letters, 2024, 35(11): 109620-. doi: 10.1016/j.cclet.2024.109620
3. [3]
  Xiangqian Cao , Chenkai Yang , Xiaodong Zhu , Mengxin Zhao , Yilin Yan , Zhengnan Huang , Jinming Cai , Jingming Zhuang , Shengzhou Li , Wei Li , Bing Shen . Synergistic enhancement of chemotherapy for bladder cancer by photothermal dual-sensitive nanosystem with gold nanoparticles and PNIPAM. Chinese Chemical Letters, 2024, 35(8): 109199-. doi: 10.1016/j.cclet.2023.109199
4. [4]
  Si Ha , Jiacheng Zhu , Hua Xiang , Guoshun Luo . Hydrophobic tag tethering degrader as a promising paradigm of protein degradation: Past, present and future perspectives. Chinese Chemical Letters, 2024, 35(8): 109192-. doi: 10.1016/j.cclet.2023.109192
5. [5]
  Shangqian Zhang , Jiaxuan Li , Xuan Hu , Zelong Chen , Junliang Dong , Chenhao Hu , Shuang Chao , Yinghua Lv , Yuxin Pei , Zhichao Pei . H₂S and NIR light-driven nanomotors induce disulfidptosis for targeted anticancer therapy by enhancing disruption of tumor metabolic symbiosis. Chinese Chemical Letters, 2025, 36(1): 110314-. doi: 10.1016/j.cclet.2024.110314
6. [6]
  Botao QU , Qian WANG , Xiaogang NING , Yuxin ZHOU , Ruiping ZHANG . Deeply penetrating photoacoustic imaging in tumor tissues based on dual-targeted melanin nanoparticle. Chinese Journal of Inorganic Chemistry, 2024, 40(5): 1025-1032. doi: 10.11862/CJIC.20230416
7. [7]
  Zhihui Zhang , Ru Sun , Chong Bian , Hongbo Wang , Zhen Zhao , Panpan Lv , Jianzhong Lu , Haixin Zhang , Hulie Zeng , Yuanyuan Chen , Zhijuan Cao . A dual-protease-triggered chemiluminescent probe for precise tumor imaging. Chinese Chemical Letters, 2025, 36(2): 109784-. doi: 10.1016/j.cclet.2024.109784
8. [8]
  Jinyu Guo , Yandai Lin , Shaohua He , Yueqing Chen , Fenglu Li , Renjie Ruan , Gaoxing Pan , Hexin Nan , Jibin Song , Jin Zhang . Utilizing dual-responsive iridium(Ⅲ) complex for hepatocellular carcinoma: Integrating photoacoustic imaging with chemotherapy and photodynamic therapy. Chinese Chemical Letters, 2024, 35(9): 109537-. doi: 10.1016/j.cclet.2024.109537
9. [9]
  Chao Zhang , Ai-Feng Liu , Shihui Li , Fang-Yuan Chen , Jun-Tao Zhang , Fang-Xing Zeng , Hui-Chuan Feng , Ping Wang , Wen-Chao Geng , Chuan-Rui Ma , Dong-Sheng Guo . A supramolecular formulation of icariin@sulfonatoazocalixarene for hypoxia-targeted osteoarthritis therapy. Chinese Chemical Letters, 2025, 36(1): 109752-. doi: 10.1016/j.cclet.2024.109752
10. [10]
  Ting Pan , Dinghu Zhang , Guomei You , Xiaoxia Wu , Chenguang Zhang , Xinyu Miao , Wenzhi Ren , Yiwei He , Lulu He , Yuanchuan Gong , Jie Lin , Aiguo Wu , Guoliang Shao . PD-L1 targeted iron oxide SERS bioprobe for accurately detecting circulating tumor cells and delineating tumor boundary. Chinese Chemical Letters, 2025, 36(1): 109857-. doi: 10.1016/j.cclet.2024.109857
11. [11]
  Tao LIU , Yuting TIAN , Ke GAO , Xuwei HAN , Ru'nan MIN , Wenjing ZHAO , Xueyi SUN , Caixia YIN . A photothermal agent with high photothermal conversion efficiency and high stability for tumor therapy. Chinese Journal of Inorganic Chemistry, 2024, 40(8): 1622-1632. doi: 10.11862/CJIC.20240107
12. [12]
  Fengyun Li , Zerong Pei , Shuting Chen , Gen li , Mengyang Liu , Liqin Ding , Jingbo Liu , Feng Qiu . Multifunctional nano-herb based on tumor microenvironment for enhanced tumor therapy of gambogic acid. Chinese Chemical Letters, 2024, 35(5): 108752-. doi: 10.1016/j.cclet.2023.108752
13. [13]
  Hao Cai , Xiaoyan Wu , Lei Jiang , Feng Yu , Yuxiang Yang , Yan Li , Xian Zhang , Jian Liu , Zijian Li , Hong Bi . Lysosome-targeted carbon dots with a light-controlled nitric oxide releasing property for enhanced photodynamic therapy. Chinese Chemical Letters, 2024, 35(4): 108946-. doi: 10.1016/j.cclet.2023.108946
14. [14]
  Jia-Qi Feng , Xiang Tian , Rui-Ge Cao , Yong-Xiu Li , Wen-Long Liu , Rong Huang , Si-Yong Qin , Ai-Qing Zhang , Yin-Jia Cheng . An AIE-based theranostic nanoplatform for enhanced colorectal cancer therapy: Real-time tumor-tracking and chemical-enhanced photodynamic therapy. Chinese Chemical Letters, 2024, 35(12): 109657-. doi: 10.1016/j.cclet.2024.109657
15. [15]
  Yunkang Tong , Haiqiao Huang , Haolan Li , Mingle Li , Wen Sun , Jianjun Du , Jiangli Fan , Lei Wang , Bin Liu , Xiaoqiang Chen , Xiaojun Peng . Cooperative bond scission by HRP/H₂O₂ for targeted prodrug activation. Chinese Chemical Letters, 2024, 35(12): 109663-. doi: 10.1016/j.cclet.2024.109663
16. [16]
  Cheng-Zhe Gao , Hao-Ran Jia , Tian-Yu Wang , Xiao-Yu Zhu , Xiaofeng Han , Fu-Gen Wu . A dual drug-loaded tumor vasculature-targeting liposome for tumor vasculature disruption and hypoxia-enhanced chemotherapy. Chinese Chemical Letters, 2025, 36(1): 109840-. doi: 10.1016/j.cclet.2024.109840
17. [17]
  Yihao Zhang , Yang Jiao , Xianchao Jia , Qiaojia Guo , Chunying Duan . Highly effective self-assembled porphyrin MOCs nanomaterials for enhanced photodynamic therapy in tumor. Chinese Chemical Letters, 2024, 35(5): 108748-. doi: 10.1016/j.cclet.2023.108748
18. [18]
  Zhe Li , Ping-Zhao Liang , Li Xu , Fei-Yu Yang , Tian-Bing Ren , Lin Yuan , Xia Yin , Xiao-Bing Zhang . Three positive charge nonapoptotic-induced photosensitizer with excellent water solubility for tumor therapy. Chinese Chemical Letters, 2024, 35(8): 109190-. doi: 10.1016/j.cclet.2023.109190
19. [19]
  An Lu , Yuhao Guo , Yi Yan , Lin Zhai , Xiangyu Wang , Weiran Cao , Zijie Li , Zhixia Zhao , Yujie Shi , Yuanjun Zhu , Xiaoyan Liu , Huining He , Zhiyu Wang , Jian-Cheng Wang . Nanomedicine integrating the lipidic derivative of 5-fluorouracil, miriplatin and PD-L1 siRNA for enhancing tumor therapy. Chinese Chemical Letters, 2024, 35(6): 108928-. doi: 10.1016/j.cclet.2023.108928
20. [20]
  Ji Liu , Dongsheng He , Tianjiao Hao , Yumin Hu , Yan Zhao , Zhen Li , Chang Liu , Daquan Chen , Qiyue Wang , Xiaofei Xin , Yan Shen . Gold mineralized "hybrid nanozyme bomb" for NIR-II triggered tumor effective permeation and cocktail therapy. Chinese Chemical Letters, 2024, 35(9): 109296-. doi: 10.1016/j.cclet.2023.109296

Get Citation

PDF

XML

Metrics

PDF Downloads(5)
Abstract views(888)
HTML views(26)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Fabrication of doxorubicin and chlorotoxin-linked Eu-Gd2O3 nanorods with dual-model imaging and targeted therapy of brain tumor

Metrics

通讯作者: 陈斌, bchen63@163.com

Fabrication of doxorubicin and chlorotoxin-linked Eu-Gd₂O₃ nanorods with dual-model imaging and targeted therapy of brain tumor